Though about 80 percent of the time I smoke energetic sativa strains, I do enjoy a strong and sedating indica for late at night. More and more, I have preferred to go with early kush and landrace strains. When I saw the lineage of CS Kush by Rythm, I picked up from Rise Effingham an eighth to sample and review.
CS Kush is an indica-leaning hybrid cross of 92 OG and Afgooey. This eighth tested at 21.07% THCa, 0.71% THC, 0.41% CBGa, and 21.78% total cannabinoids. The leading terpenes included limonene, β-caryophyllene, β-myrcene, linalool, and α-pinene.
The eighth contained several small buds with white trichomes and wild flaring orange pistils. The color of the buds varied from dark to light green. The aroma hit heavy with earthy hops, sweet wheatgrass, and kush with hints of dirt, wood, pine, and spicy citrus.
The flavor delivered earthy pine, kush, and sweet hops on the front end of the inhale. The back end of the inhale provided an extra boost of sweetness with notes of earthy pine and kush. The aftertaste left a creamy and earthy sweetness on the tongue.
The effects provided the heavy body buzz I expected, but the head high was more clearheaded than expected. Though relatively clearheaded, the head high onset started with a punch from the first hit and after an upbeat start became more and more sedating as the buzz continued.
The body buzz also had a quick onset and didn’t take long to envelope the entire body. The complete body buzz provided long relief from cramps and soreness. The buzz was relaxing but not debilitating, de-stressing but numbing.
I was able to function and break any couchlock or thoughtlock that I put myself into, binge television, listen to music, and more. The end of the buzz carried most of the sedation and tiredness, and that led to a boost in appetite and eventually into uninterrupted sleep. For more Illinois News Joint reviews, visit here.
To qualify and receive a medical patient card at a discounted rate, visit here.
To learn more about cannabis-friendly events in Illinois, visit here.
For more Illinois cannabis industry news, visit here.
FDA Disclaimer: The statements made regarding these products have not been evaluated by the Food and Drug Administration. The efficacy of these products has not been confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure or prevent any disease. All information presented here is not meant as a substitute for or alternative to information from healthcare practitioners. Please consult your healthcare professional about potential interactions or other possible complications before using any product.
Effects & Medical Attributes are based on anecdotal evidence. Individual experiences can be varied.